Sign In
to Vote &
Create Storyboards.
 

Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy

New England Journal of Medicine - 23 Oct 2026 04:30
New England Journal of Medicine, Ahead of Print.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard